Nov 14 2026in 56 days
$9.85
$12.25B
8 of last 12
Each report against the estimate that stood when it landed.
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Jul 27 2026 | $7.91 | $8.80 | +11.3% | $12.21B | $12.08B | -1.1% |
| May 7 2026 | $8.17 | $8.60 | +5.3% | $10.58B | $12.24B | +15.7% |
| Feb 4 2026 | $6.26 | $7.50 | +19.8% | $10.26B | $10.51B | +2.4% |
| Nov 5 2025 | $5.46 | $7.60 | +39.2% | $9.74B | $11.27B | +15.7% |
| Aug 5 2025 | $6.50 | $5.40 | -16.9% | $8.68B | $10.56B | +21.6% |
| May 5 2025 | $5.03 | $7.70 | +53.1% | $8.19B | $8.36B | +2.0% |
| Feb 5 2025 | $5.26 | $4.70 | -10.6% | $7.79B | $7.58B | -2.6% |
| Nov 5 2024 | $5.43 | $5.54 | +2.0% | $7.70B | $7.43B | -3.4% |
| Aug 7 2024 | $4.55 | $5.36 | +17.8% | $7.69B | $7.73B | +0.6% |
| May 11 2024 | $4.65 | $4.89 | +5.2% | $6.30B | $7.27B | +15.4% |
| Feb 5 2024 | $5.50 | $4.75 | -13.6% | $6.59B | $6.64B | +0.9% |
| Nov 4 2023 | $5.17 | $4.57 | -11.6% | $6.03B | $6.08B | +0.8% |
No earnings transcripts available for CCL.NS
Transcripts may not be available for all companies
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $49.20B | $57.05B | $65.73B | $77.56B |
| Low | $45.83B | $53.30B | $61.32B | $72.36B |
| High | $51.48B | $59.49B | $68.64B | $81.00B |
| EBITDA Avg | $9.36B | $11.77B | $14.22B | $17.10B |
| Low | $9.07B | $11.09B | $13.46B | $16.18B |
| High | $9.61B | $12.33B | $14.72B | $17.71B |
| EBIT Avg | $6.89B | $8.36B | $9.82B | $11.62B |
| Low | $6.61B | $7.67B | $9.06B | $10.70B |
| High | $7.15B | $8.92B | $10.32B | $12.22B |
| Net Income Avg | $5.06B | $6.33B | $7.60B | $9.16B |
| Low | $4.81B | $5.74B | $6.94B | $8.36B |
| High | $5.28B | $6.82B | $8.04B | $9.69B |
| EPS Avg | $37.96 | $47.47 | $57.00 | $68.70 |
| Low | $36.10 | $43.01 | $52.03 | $62.71 |
| High | $39.61 | $51.12 | $60.29 | $72.66 |
| Analysts (Rev / EPS) | 12 / 12 | 11 / 11 | 5 / 4 | 6 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $12.25B | $11.85B | $11.94B |
| Low | $12.25B | $11.85B | $11.94B |
| High | $12.25B | $11.85B | $11.94B |
| EBITDA Avg | $2.27B | $2.34B | $2.43B |
| Low | $2.27B | $2.34B | $2.43B |
| High | $2.27B | $2.34B | $2.43B |
| EBIT Avg | $1.82B | $1.84B | $1.88B |
| Low | $1.82B | $1.84B | $1.88B |
| High | $1.82B | $1.84B | $1.88B |
| Net Income Avg | $1.31B | $1.33B | $1.37B |
| Low | $1.31B | $1.33B | $1.37B |
| High | $1.31B | $1.33B | $1.37B |
| EPS Avg | $9.85 | $10.00 | $10.25 |
| Low | $9.85 | $10.00 | $10.25 |
| High | $9.85 | $10.00 | $10.25 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |